Vanguard Russell 2000 ETF (VTWO)

92.70 +1.99  +2.19% NASDAQ Mar 30, 16:59 Delayed 2m USD
View Full Chart
Price Chart

Key Stats

Net Asset Value 90.56
Discount or Premium to NAV 0.17%
Turnover Ratio 16.00%
1 Year Fund Level Flows -354.46M

Performance & Returns

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -24.11% -24.30% -25.28% 33
3M -31.81% -31.90% -33.62% 27
6M -24.92% -24.99% -28.16% 19
YTD -31.79% -31.91% -33.61% 28
1Y -24.35% -24.45% -27.04% 28
3Y -4.45% -4.52% -6.78% 23
5Y -0.36% -0.39% -1.97% 23
10Y -- -- 5.77% --
15Y -- -- 4.88% --
20Y -- -- 5.83% --
As of March 27, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 2.13% 2.13% 0.00%
Stock 97.87% 97.87% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of Feb. 29, 2020

Region Exposure

Americas 99.60%
North America 99.33%
Latin America 0.27%
Greater Europe 0.21%
United Kingdom 0.04%
Europe Developed 0.11%
Europe Emerging 0.02%
Africa/Middle East 0.04%
Greater Asia 0.18%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.12%
Asia Emerging 0.06%
Market Classification
% Developed Markets 99.90%
% Emerging Markets 0.10%
As of Feb. 29, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 3.24%
Communication Services 2.69%
Consumer Cyclical 9.56%
Consumer Defensive 3.79%
Energy 2.28%
Financial Services 15.84%
Healthcare 18.84%
Industrials 16.58%
Real Estate 9.46%
Technology 13.87%
Utilities 3.85%
As of Feb. 29, 2020

Stock Market Capitalization

Giant 0.00%
Large 0.21%
Medium 18.34%
Small 68.59%
Micro 12.87%
As of Feb. 29, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 0.22%
Mid Cap Value 3.84%
Mid Cap Blend 5.55%
Mid Cap Growth 9.31%
Small Cap Value 22.54%
Small Cap Blend 28.96%
Small Cap Growth 29.58%
As of Feb. 29, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
TDOC Teladoc Health Inc 0.48% 163.25 -0.55%
NVCR NovoCure Ltd 0.33% 70.00 +6.87%
GNRC Generac Holdings Inc 0.33% 93.00 +4.54%
LITE Lumentum Holdings Inc 0.32% 74.09 +5.84%
TREX Trex Co Inc 0.30% 85.11 +2.72%
HAE Haemonetics Corp 0.29% 101.74 +0.78%
AMED Amedisys Inc 0.29% 179.43 +8.08%
REXR Rexford Industrial Realty Inc 0.27% 41.26 +5.01%
TECD Tech Data Corp 0.27% 131.17 +0.41%
HQY HealthEquity Inc 0.26% 52.79 +1.70%
As of Feb. 29, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks to track the performance of a benchmark index that measures the investment return of small-capitalization stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the Russell 2000® Index. The index is designed to measure the performance of small-capitalization stocks in the United States. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Blend
Prospectus Objective Small Company
Fund Owner Firm Name Vanguard
Benchmark Index
Russell 2000 TR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Michael Johnson 4.19 yrs
Walter Nejman 4.50 yrs

Net Fund Flows

1M -70.43M
3M -34.06M
6M -297.98M
YTD -4.879M
1Y -354.46M
3Y 317.29M
5Y 878.29M
10Y --
As of Feb. 29, 2020

Risk Info

Beta (5Y) 1.144
Max Drawdown (All) 29.01%
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.8103
30-Day Rolling Volatility 84.48%
Daily Value at Risk (VaR) 1% (All) 3.18%
Monthly Value at Risk (VaR) 1% (All) 12.89%

Fundamentals

Dividend Yield TTM (3-30-20) 1.90%
30-Day SEC Yield (3-27-20) 1.47%
7-Day SEC Yield --
Weighted Average PE Ratio 16.35
Weighted Average Price to Sales Ratio 1.048
Weighted Average Price to Book Ratio 1.833
Weighted Median ROE 4.80%
Weighted Median ROA -0.45%
Forecasted Dividend Yield 1.71%
Forecasted PE Ratio 14.88
Forecasted Price to Sales Ratio 0.9691
Forecasted Price to Book Ratio 1.645
Number of Holdings 2001
As of Feb. 29, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 11.53%
Forecasted Book Value Growth 3.58%
Forecasted Cash Flow Growth 4.63%
Forecasted Earnings Growth 6.78%
Forecasted Revenue Growth 3.41%
As of Feb. 29, 2020

Comparables

Edit

Attributes

Key Dates
Inception Date 9/20/2010
Termination Date
Last Annual Report Date 8/31/2019
Last Prospectus Date 12/20/2019
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.